Neffy, a single-dose nasal spray administered into one nostril, was approved for use in adult and pediatric patients who weigh at least 30 kilograms | Credit:...
The US Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit’s drug for a chronic inflammatory liver disease. 2 min read Last...